BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 9528925)

  • 1. Up-regulation of insulin-like growth factor binding protein-5 is independent of muscle cell differentiation, sensitive to rapamycin, but insensitive to wortmannin and LY294002.
    Rousse S; Montarras D; Pinset C; Dubois C
    Endocrinology; 1998 Apr; 139(4):1487-93. PubMed ID: 9528925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p70 S6 kinase activation is not required for insulin-like growth factor-induced differentiation of rat, mouse, or human skeletal muscle cells.
    Canicio J; Gallardo E; Illa I; Testar X; Palacín M; Zorzano A; Kaliman P
    Endocrinology; 1998 Dec; 139(12):5042-9. PubMed ID: 9832443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphatidylinositol 3-kinase and p70 s6 kinase participate in the regulation of protein turnover in skeletal muscle by insulin and insulin-like growth factor I.
    Dardevet D; Sornet C; Vary T; Grizard J
    Endocrinology; 1996 Oct; 137(10):4087-94. PubMed ID: 8828461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of PTEN on the expression of insulin-like growth factors (IGFs) and IGF-binding proteins in human gastric adenocarcinoma cells.
    Yi HK; Kim SY; Hwang PH; Kim CY; Yang DH; Oh Y; Lee DY
    Biochem Biophys Res Commun; 2005 May; 330(3):760-7. PubMed ID: 15809062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upstream mechanisms of glycogen synthase activation by insulin and insulin-like growth factor-I. Glycogen synthase activation is antagonized by wortmannin or LY294002 but not by rapamycin or by inhibiting p21ras.
    Yamamoto-Honda R; Tobe K; Kaburagi Y; Ueki K; Asai S; Yachi M; Shirouzu M; Yodoi J; Akanuma Y; Yokoyama S
    J Biol Chem; 1995 Feb; 270(6):2729-34. PubMed ID: 7852343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphatidylinositol 3'-kinase and p70s6k are required for insulin but not bisperoxovanadium 1,10-phenanthroline (bpV(phen)) inhibition of insulin-like growth factor binding protein gene expression. Evidence for MEK-independent activation of mitogen-activated protein kinase by bpV(phen).
    Band CJ; Posner BI
    J Biol Chem; 1997 Jan; 272(1):138-45. PubMed ID: 8995239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of phosphatidylinositol 3-kinase, protein kinase B, and p70 S6 kinases in lipopolysaccharide-stimulated Raw 264.7 cells: differential effects of rapamycin, Ly294002, and wortmannin on nitric oxide production.
    Salh B; Wagey R; Marotta A; Tao JS; Pelech S
    J Immunol; 1998 Dec; 161(12):6947-54. PubMed ID: 9862729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways.
    Coolican SA; Samuel DS; Ewton DZ; McWade FJ; Florini JR
    J Biol Chem; 1997 Mar; 272(10):6653-62. PubMed ID: 9045696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential requirements of the MAP kinase and PI3 kinase signaling pathways in Src- versus insulin and IGF-1 receptors-induced growth and transformation of rat intestinal epithelial cells.
    Nguyen KT; Wang WJ; Chan JL; Wang LH
    Oncogene; 2000 Nov; 19(47):5385-97. PubMed ID: 11103940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscle-specific overexpression of the type 1 IGF receptor results in myoblast-independent muscle hypertrophy via PI3K, and not calcineurin, signaling.
    Quinn LS; Anderson BG; Plymate SR
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1538-51. PubMed ID: 17940216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor (IGF)-I regulates IGF-binding protein-5 gene expression through the phosphatidylinositol 3-kinase, protein kinase B/Akt, and p70 S6 kinase signaling pathway.
    Duan C; Liimatta MB; Bottum OL
    J Biol Chem; 1999 Dec; 274(52):37147-53. PubMed ID: 10601276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor (IGF)-binding protein-related protein-1: an autocrine/paracrine factor that inhibits skeletal myoblast differentiation but permits proliferation in response to IGF.
    Haugk KL; Wilson HM; Swisshelm K; Quinn LS
    Endocrinology; 2000 Jan; 141(1):100-10. PubMed ID: 10614628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of insulin-like growth factor actions in L6A1 myoblasts by insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5: a dual role for IGFBP-5.
    Ewton DZ; Coolican SA; Mohan S; Chernausek SD; Florini JR
    J Cell Physiol; 1998 Oct; 177(1):47-57. PubMed ID: 9731744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mitogen-activated protein kinase pathway tonically inhibits both basal and IGF-I-stimulated IGF-binding protein-5 production in mammary epithelial cells.
    Fleming JM; Brandimarto JA; Cohick WS
    J Endocrinol; 2007 Aug; 194(2):349-59. PubMed ID: 17641284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid activation of insulin-like growth factor binding protein-5 gene transcription during myoblast differentiation.
    Rotwein P; James PL; Kou K
    Mol Endocrinol; 1995 Jul; 9(7):913-23. PubMed ID: 7476973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of insulin-like growth factor (IGF) receptors and IGF-binding proteins in IGF-II-induced proliferation and differentiation of L6A1 rat myoblasts.
    Bach LA; Salemi R; Leeding KS
    Endocrinology; 1995 Nov; 136(11):5061-9. PubMed ID: 7588242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of wortmannin and rapamycin on CSF-1-mediated responses in macrophages.
    Hamilton JA; Byrne R; Whitty G; Vadiveloo PK; Marmy N; Pearson RB; Christy E; Jaworowski A
    Int J Biochem Cell Biol; 1998 Feb; 30(2):271-83. PubMed ID: 9608681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor 1 inhibits apoptosis using the phosphatidylinositol 3'-kinase and mitogen-activated protein kinase pathways.
    Párrizas M; Saltiel AR; LeRoith D
    J Biol Chem; 1997 Jan; 272(1):154-61. PubMed ID: 8995241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of the Ras/extracellular signal-regulated kinase signalling pathway in the regulation of ERCC-1 mRNA levels by insulin.
    Lee-Kwon W; Park D; Bernier M
    Biochem J; 1998 Apr; 331 ( Pt 2)(Pt 2):591-7. PubMed ID: 9531502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of protein synthesis by cholecystokinin in rat pancreatic acini involves PHAS-I and the p70 S6 kinase pathway.
    Bragado MJ; Groblewski GE; Williams JA
    Gastroenterology; 1998 Sep; 115(3):733-42. PubMed ID: 9721171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.